Khandelwal Laboratories Pvt Ltd
Etoricoxib (60mg) + Paracetamol (325mg)
Xibra P 60mg/325mg Tablet is a pain-relieving medicine used to reduce pain and inflammation in conditions like rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis.
Tablet
Xibra P 60mg/325mg Tablet is a combination of two medicines: Etoricoxib and Paracetamol. Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) and Paracetamol is an antipyretic (fever reducer). They work by blocking the release of certain chemical messengers in the brain that cause pain and fever. Xibra P 60mg/325mg Tablet can be taken with or without food. You should take it regularly as advised by your doctor. Your doctor may change the dose and time between doses according to your pain level and your needs. Do not take more or use it for a longer duration than recommended by your doctor.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Xibra P 60mg/325mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Diarrhea Indigestion Stomach pain Flatulence Swelling of hands and feet Flu-like symptoms
It is unsafe to consume alcohol with Xibra P 60mg/325mg Tablet.
Information regarding the use of Xibra P 60mg/325mg Tablet during breastfeeding is not available. Please consult your doctor.
Xibra P 60mg/325mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Xibra P 60mg/325mg Tablet is a combination of two medicines: Etoricoxib and Paracetamol. Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) and Paracetamol is an antipyretic (fever reducer). They work by blocking the release of certain chemical messengers in the brain that cause pain and fever.
You have been prescribed Xibra P 60mg/325mg Tablet to get relief from pain and inflammation. You can take the tablet either with or without food. During long-term treatment, your doctor may want to take regular blood tests to monitor your liver function. If you have asthma, symptoms such as wheeze or breathlessness can be made worse by Xibra P 60mg/325mg Tablet. If this happens to you, see your doctor as soon as possible.
Yes, some patients may experience dizziness (feeling faint, weak, unsteady or lightheaded) when taking Xibra P 60mg/325mg Tablet. If you experience dizziness, it is advisable to rest until the symptoms subside.
The use of Xibra P 60mg/325mg Tablet is not recommended for patients with a known allergy to painkillers (NSAIDs) or any of the components or excipients in this medication. It should also be avoided in patients with a history of: * Stomach ulcers or active, recurrent stomach ulcer / bleeding * Heart failure * High blood pressure * Liver or kidney disease
Prolonged use of Xibra P 60mg/325mg Tablet may lead to kidney damage. This is because this medication can reduce prostaglandins in the body, which protect the kidneys from harm.
Taking higher doses of Xibra P 60mg/325mg Tablet will not make it more effective. It may even lead to increased side effects. If your symptoms worsen, consult your doctor for a reevaluation.
Xibra P 60mg/325mg Tablet contains Paracetamol. It is important to note that paracetamol, in doses above the recommended level, can be harmful to the liver. Additionally, consuming alcohol while taking this medication may increase your risk of liver damage. If you have pre-existing liver disease, it is advisable to avoid using Xibra P 60mg/325mg Tablet.
Store this medication in its original container, tightly sealed. Follow any specific instructions mentioned on the packaging or label. Do not dispose of the unused medicine without consulting your doctor or pharmacist.
The duration of treatment with Xibra P 60mg/325mg Tablet should be determined by your doctor. If you are using it for long-term pain relief, follow the prescribed dosage and duration unless otherwise advised.